Holen Sie sich die Stockscreener-App
2.8321
2.07%
-0.0679
Schlusskurs vom Vortag:
$2.90
Offen:
$2.92
24-Stunden-Volumen:
334.57K
Relative Volume:
1.22
Marktkapitalisierung:
$96.29M
Einnahmen:
$210.00K
Nettoeinkommen (Verlust:
$-10.12M
KGV:
-9.3407
EPS:
-0.3032
Netto-Cashflow:
$-7.12M
1W Leistung:
-9.27%
1M Leistung:
-16.96%
6M Leistung:
-4.70%
1J Leistung:
-4.70%
1-Tages-Spanne:
$2.79
$2.969
1-Wochen-Bereich:
$2.79
$3.2519
52-Wochen-Spanne:
$2.32
$5.4566
Anixa Biosciences Inc Stock (ANIX) Company Profile
Firmenname
Anixa Biosciences Inc
Sektor
Branche
Telefon
408-708-9808
Adresse
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Compare ANIX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
2.8301 | 98.67M | 210.00K | -10.12M | -7.12M | -0.3032 |
VRTX
Vertex Pharmaceuticals Inc
|
521.32 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
802.44 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,004.73 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.36 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.19 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | Maxim Group | Buy |
| 2022-12-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-04-12 | Eingeleitet | H.C. Wainwright | Buy |
Anixa Biosciences Inc Aktie (ANIX) Neueste Nachrichten
Anixa Biosciences highlights progress in breast cancer vaccine on Bloomberg TV this Saturday. - Pluang
A breast cancer survivor will discuss Anixa's vaccine on TV - Stock Titan
Anixa Biosciences Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026 - PR Newswire
Anixa Biosciences (ANIX) Projected to Post Earnings on Wednesday - MarketBeat
Anixa Biosciences Inc. (ANIX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Anixa Biosciences Inc. (ANIX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Anixa Biosciences Inc (NASDAQ:ANIX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy - AOL.ca
Breast cancer vaccine meets Phase 1 goals; ovar... - Pluang
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research - MarketBeat
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - Sahm
Anixa (ANIX) Range: Slides 2.70% to $3.61 in the Latest Reading; Level Watch - vinanet.vn
Anixa (ANIX) Latest Results Brief: EPS Prints Above Forecast at the Close; Post-Earnings Trading: Shares Finish 3.30% Lower in the Latest ReadingEBITDA Analysis - vinanet.vn
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Anixa Biosciences to present at H.C. Wainwright Global Investment Conference - Bitget
Anixa Biosciences (ANIX) Surges 7.7% as Biotech Momentum BuildsCorrective Wave - vinanet.vn
Anixa Biosciences (ANIX) Slips 0.63% to $3.18 as Shares Consolidate Between Key Support and ResistancePre-Earnings Momentum - vinanet.vn
ANIX Q2 2026 Earnings: Narrower Loss of $0.07 per Share Beats Estimates Amid Steady Pipeline Execution - vinanet.vn
Anixa Biosciences (ANIX) Holds Near $3.42 as Traders Eye Key Support and Resistance LevelsVolatility Term Structure - vinanet.vn
Anixa Biosciences (NASDAQ:ANIX) CEO Amit Kumar Buys 5,000 Shares - MarketBeat
Anixa Biosciences (ANIX) CEO Amit Kumar Buys 5,000 Shares, Insider Ownership Climbs to 657,000 Shares - GuruFocus
Anixa Biosciences CEO Amit Kumar buys $17,350 in company stock By Investing.com - Investing.com Nigeria
Form 4 Anixa Biosciences Inc For: 3 August By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 5,000 company shares - Stock Titan
Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Form 4 Anixa Biosciences Inc For: 29 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires $17,200.00 in Stock - MarketBeat
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires 3,000 Shares - MarketBeat
Anixa Biosciences (NASDAQ: ANIX) CEO buys 5,000 shares, now holds 652,000 - Stock Titan
Anixa Biosciences Inc (ANIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Form 4 Anixa Biosciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 3,188 shares at $3.37 each - Stock Titan
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock - Investing.com
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock By Investing.com - Investing.com Canada
Anixa Biosciences Inc (ANIX) CEO purchases 3,000 shares at $3.73 - Stock Titan
Anixa Biosciences Inc (ANIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anixa Biosciences Inc (ANIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anixa Biosciences, Inc. Revenue Breakdown – NASDAQ:ANIX - TradingView
Anixa Biosciences Inc (ANIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.700|Chg%:-0.050 - TradingKey
TradingKey - TradingKey
Anixa Biosciences Inc (ANIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.725|Chg%:+0.025 - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.680|Chg%:-0.020 - TradingKey
Anixa Biosciences Inc (ANIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance UK
New Strong Buy Stocks for July 22nd - The Globe and Mail
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year? - Yahoo Finance
CEO Amit Kumar Increases Stake in Anixa Biosciences Inc - GuruFocus
Finanzdaten der Anixa Biosciences Inc-Aktie (ANIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anixa Biosciences Inc-Aktie (ANIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Baskies Arnold M | Director |
Jul 27 '26 |
Option Exercise |
3.13 |
6,000 |
18,780 |
141,000 |
| KUMAR AMIT | Chief Executive Officer |
Jul 27 '26 |
Buy |
3.44 |
5,000 |
17,200 |
652,000 |
| KUMAR AMIT | Chief Executive Officer |
Jul 27 '26 |
Buy |
3.37 |
3,188 |
10,744 |
647,000 |
| KUMAR AMIT | Chief Executive Officer |
Jul 24 '26 |
Buy |
3.73 |
3,000 |
11,190 |
643,812 |
| KUMAR AMIT | Chief Executive Officer |
Jul 20 '26 |
Buy |
3.46 |
5,000 |
17,300 |
640,812 |
| Titterton Lewis H jr | Director |
Jul 20 '26 |
Buy |
3.47 |
12,000 |
41,640 |
986,967 |
| Titterton Lewis H jr | Director |
Jul 15 '26 |
Buy |
3.28 |
2,797 |
9,174 |
974,967 |
| KUMAR AMIT | Chief Executive Officer |
Jul 10 '26 |
Buy |
3.04 |
5,000 |
15,200 |
635,812 |
| Titterton Lewis H jr | Director |
Jun 16 '26 |
Buy |
2.64 |
2,836 |
7,487 |
972,170 |
| KUMAR AMIT | Chief Executive Officer |
Jun 12 '26 |
Buy |
2.50 |
21,000 |
52,500 |
630,812 |
0.69%
3.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):